| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |